Results 21 to 30 of about 249,295 (264)

Naming Commission Final Report: Part 2

, 2022
Report summarizing the recommendations of The Naming Commission's findings regarding military academies in the United States as mandated by the National Defense Authorization Act for Fiscal Year 2021, which mandates the removal of names, symbols ...
United States. Naming Commission.
core  

Naming Commission Final Report: Part 1

, 2022
Report summarizing the recommendations of The Naming Commission's findings regarding army bases as mandated by the National Defense Authorization Act for Fiscal Year 2021, which mandates the removal of names, symbols, displays, monuments and ...
United States. Naming Commission.
core  

Reconciliation in Place Names: Why Principled Frameworks Always Matter, But Especially Now at this Political Moment

Parks Stewardship Forum
On November 19, 2021, Deb Haaland, secretary of the interior, issued two orders that launched a watershed federal effort to confront and begin healing from the harmful legacy of derogatory place names on federal lands across the United States.
Derek H. Alderman, Christine K. Johnson
doaj   +1 more source

The Naming Commission

, 2022
Website documenting the work of the Naming Commission, including their final report and recommendations regarding Department of Defense assets (e.g., names, symbols, displays, monuments, or paraphernalia) that commemorate the efforts of the Confederate ...
United States. Naming Commission.
core  

Central Nervous System Tumors Among Infants in Canada: A Report From CYP‐C

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Central nervous system (CNS) tumors in infants are rare, pose unique clinical challenges, and lack large‐scale evidence‐based data to guide management. This study seeks to describe CNS tumors in Canadian infants and to compare their outcomes with those of older children.
Samuel Sassine, Hallie Coltin, Sylvia Cheng, Lucie Lafay‐Cousin, Vanan Issai Magimairajan, Craig Erker, Stéphanie Vairy, Lynette Bowes, Adam Fleming, Donna Johnston, Sarah McKillop, Roona Sinha, Julie Bennett, Christina Coleman, Laura Wheaton, Shayna Zelcer, Samuele Renzi, Thai Hoa Tran   +17 more
wiley   +1 more source

MerTK inhibitor suppresses melanoma growth in mice by regulating the quantity and phenotype of tumor-associated macrophages

Pifu-xingbing zhenliaoxue zazhi
[Objective] To investigate the effect of the MerTK inhibitor UNC2250 on tumor growth in melanoma mice and to preliminarily elucidate its mechanism of action.
WU Naming, SHA Shanshan, YANG Liu
doaj   +1 more source

Impact of Radiation Therapy on Physical and Psychosocial Health of Adolescents and Young Adults: A Joint Report From the Children's Oncology Group AYA and Radiation Oncology Committees

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Rates of cancer among adolescents and young adults (AYA), age 15–39 years, are increasing. Consequently, radiation oncologists are treating more AYAs who have diagnoses spanning both pediatric and adult practices. Compared to pediatric and older adult patients, AYAs face a unique set of challenges.
Hesham Elhalawani, Rachel K. Peterson, Avani D. Rao, Laurie J. McKenzie, Ahmed Magdy Elmotayam, Leslie Chang, Michael Roth, Susan L. McGovern   +7 more
wiley   +1 more source

Pediatric Idiopathic Multicentric Castleman Disease Is Often Severe But Responsive to Siltuximab

Pediatric Blood &Cancer, EarlyView.
ABSTRACT Background Idiopathic multicentric Castleman disease (iMCD) is a potentially fatal immunologic disorder marked by widespread lymphadenopathy and inflammation. Siltuximab, an interleukin‐6 (IL‐6) inhibitor, is the only FDA‐approved treatment for adult patients with iMCD.
Bridget Austin, Sheila K. Pierson, Kelley C. Dacus, Mateo Sarmiento Bustamante, Saishravan Shyamsundar, Larissa Borys, Kayla McHugh, Abiola Irvine, Yoojin Jo, Adam Bagg, Mary Jo Lechowicz, Daisy Alapat, Amy Chadburn, Megan S. Lim, Gordan Srkalovic, Frits van Rhee, David C. Fajgenbaum, Joshua D. Brandstadter   +17 more
wiley   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

Therapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye, Chimezie Okwuonu, Evelyn Idam, Folasade Adelekan‐Popoola, Shakirat Gold‐Olufadi, Olufunto Olufela Kalejaiye, Abdullateef Ogala, Zinnah Aloziem, Blossom Amamchukwu, Patience Elimia, Mkpoikanabasi Obot‐Obot, Henry Mbakwe, Praises Maduagwuna, Olatunji Akinrodoye, Chiamaka Anyanwu, Benjamin Anyanwu, Adedamola Akinsiku, Oluwatoyin A. Akinsiku, Muzamil O. Hassan, Fatiu A. Arogundade, Olalekan E. Ojo, Homayemem Weli, Jesupelumi Adenihun, Aderemi Adelaja, Ebun Bamgboye, Olalekan Olatise, Ade E. Faponle, Ayoola Odeyemi, Michael Muoka, Stephen Asaolu, Qudrat Busari, Blessing Dawudu, Michael Naiyeju, Rasheed A. Balogun   +33 more
wiley   +1 more source

Contextual diversity, not word frequency, determines word-naming and lexical decision times [PDF]

Word frequency is an important predictor of word-naming and lexical decision times. It is, however, confounded with contextual diversity, the number of contexts in which a word has been seen.
Quesada, José F, Adelman, James S., Brown, G. D. A. (Gordon D. A.)   +2 more
core   +1 more source